Nanoformulation of Drug Delivery Systems for Natural Products

Dear Colleagues,

Pharmaceutical nanotechnology is an emerging area of science that combines nanotechnology with pharmaceutical and biomedical sciences and focuses on improved medicines through the design, formulation and characterisation of nanotechnology-based drug delivery systems (DDSs). Today, the interest in applying novel nanotechnology strategies for the formulation of natural products (i.e., for the active ingredients or extracts originating from plants, minerals or animals) is steadily increasing due to the well-documented benefits associated with the use of such DDSs. It is evident that new nanotechnology-based DDSs provide, for example, improvements in the therapeutic efficiency of native-origin active ingredients, the reduction of dose and adverse effects, and improvements in the stability of the final product. The aim of the present Special Issue is to provide a publication platform for research works presenting the recent advancements in the integration of pharmaceutical nanotechnology with natural products in developing modern DDSs. The advanced pharmaceutical nanocarrier systems integrated with natural products could be (but are not limited to) polymeric nanoparticles, solid lipid nanoparticles, liposomes, nanocrystals, nanofibers, polymersomes, exosomes, nanomicelles, dendrimers, quantum dots, and carbon nanotubes. Such nanotechnology-based DDSs could be designed for gastrointestinal delivery, topical skin (wound) and transdermal delivery, parenteral delivery, ocular delivery, pulmonary delivery, rectal delivery and theranostics applications, among others.

Prof. Dr. Jyrki Heinämäki
Prof. Dr. Ain Raal
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.